Group companies, including Ashok Leyland, will target cell and battery manufacturing for the EV ecosystem, while AstraZeneca will invest RS 716 crore to expand its existing innovation and tech centre
Group companies, including Ashok Leyland, will target cell and battery manufacturing for the EV ecosystem, while AstraZeneca will invest RS 716 crore to expand its existing innovation and tech centre by Soban News (international And National News)
